Equity Overview
Price & Market Data
Price: $2.50
Daily Change: -$0.0638 / 2.56%
Range: $2.39 - $2.61
Market Cap: $21,452,508
Volume: 17,527
Performance Metrics
1 Week: -7.25%
1 Month: 14.45%
3 Months: 4.39%
6 Months: -11.37%
1 Year: -32.02%
YTD: -16.28%
Company Details
Employees: 26
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.